165 related articles for article (PubMed ID: 32610794)
1. Deliberative Processes by Health Technology Assessment Agencies: A Reflection on Legitimacy, Values and Patient and Public Involvement Comment on "Use of Evidence-informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe".
Goetghebeur M; Cellier M
Int J Health Policy Manag; 2021 Mar; 10(4):228-231. PubMed ID: 32610794
[TBL] [Abstract][Full Text] [Related]
2. Evidence-Informed Deliberative Processes for HTA Around the Globe: Exploring the Next Frontiers of HTA and Best Practices Comment on "Use of Evidence-informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe".
Gopinathan U; Ottersen T; Cyr PR; Chalkidou K
Int J Health Policy Manag; 2021 Mar; 10(4):232-236. PubMed ID: 32772012
[TBL] [Abstract][Full Text] [Related]
3. Value Assessment Frameworks for HTA Agencies: The Organization of Evidence-Informed Deliberative Processes.
Baltussen R; Jansen MPM; Bijlmakers L; Grutters J; Kluytmans A; Reuzel RP; Tummers M; der Wilt GJV
Value Health; 2017 Feb; 20(2):256-260. PubMed ID: 28237205
[TBL] [Abstract][Full Text] [Related]
4. Use of Evidence-Informed Deliberative Processes - Learning by Doing Comment on "Use of Evidence-informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe".
Culyer AJ
Int J Health Policy Manag; 2020 Jun; 9(6):263-265. PubMed ID: 32613796
[TBL] [Abstract][Full Text] [Related]
5. HTA Agencies Need Evidence-Informed Deliberative Processes Comment on "Use of Evidence-Informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe".
Schlander M
Int J Health Policy Manag; 2021 Mar; 10(3):158-161. PubMed ID: 32610783
[TBL] [Abstract][Full Text] [Related]
6. Evidence-Informed Deliberative Processes for UHC: Progress, Potential and Prudence Comment on "Evidence-Informed Deliberative Processes for Health Benefit Package Design - Part II: A Practical Guide".
Gopinathan U
Int J Health Policy Manag; 2023; 12():7541. PubMed ID: 37579471
[TBL] [Abstract][Full Text] [Related]
7. Three Approaches to Improve a Practical Guide on Evidence-Informed Deliberative Processes for Health Benefit Package Design Comment on "Evidence-Informed Deliberative Processes for Health Benefit Package Design - Part II: A Practical Guide".
Guzman J
Int J Health Policy Manag; 2023; 12():7502. PubMed ID: 36086853
[TBL] [Abstract][Full Text] [Related]
8. Fair Processes for Priority Setting: Putting Theory into Practice Comment on "Expanded HTA: Enhancing Fairness and Legitimacy".
Jansen MP; Helderman JK; Boer B; Baltussen R
Int J Health Policy Manag; 2017 Jan; 6(1):43-47. PubMed ID: 28005541
[TBL] [Abstract][Full Text] [Related]
9. Use of Evidence-Informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe.
Oortwijn W; Jansen M; Baltussen R
Int J Health Policy Manag; 2020 Jan; 9(1):27-33. PubMed ID: 31902192
[TBL] [Abstract][Full Text] [Related]
10. Challenges and Opportunities for Deliberative Processes for Healthcare Decision-Making Comment on "Evidence-Informed Deliberative Processes for Health Benefit Package Design - Part II: A Practical Guide".
Bond K
Int J Health Policy Manag; 2023; 12():7458. PubMed ID: 35988028
[TBL] [Abstract][Full Text] [Related]
11. Evidence-Informed Deliberative Processes for Health Benefit Package Design - Part II: A Practical Guide.
Oortwijn W; Jansen M; Baltussen R
Int J Health Policy Manag; 2022 Oct; 11(10):2327-2336. PubMed ID: 34923809
[TBL] [Abstract][Full Text] [Related]
12. Evidence-Informed Deliberative Processes for Legitimate Health Benefit Package Design - Part I: Conceptual Framework.
Baltussen R; Jansen M; Oortwijn W
Int J Health Policy Manag; 2022 Oct; 11(10):2319-2326. PubMed ID: 34923808
[TBL] [Abstract][Full Text] [Related]
13. Moral and Social Values in Evidence-Informed Deliberative Processes for Health Benefit Package Design Comment on "Evidence-Informed Deliberative Processes for Health Benefit Package Design - Part II: A Practical Guide".
DiStefano MJ
Int J Health Policy Manag; 2023; 12():7480. PubMed ID: 37579447
[TBL] [Abstract][Full Text] [Related]
14. Deliberative processes in decision making informed by health technology assessment in Latin America.
Alcaraz A; Pichon-Riviere A; García-Martí S; Alfie V; Augustovski F; Castro H
Int J Technol Assess Health Care; 2022 Dec; 38(1):e86. PubMed ID: 36524558
[TBL] [Abstract][Full Text] [Related]
15. Expanded HTA: Enhancing Fairness and Legitimacy.
Daniels N; Porteny T; Urritia J
Int J Health Policy Manag; 2015 Nov; 5(1):1-3. PubMed ID: 26673643
[TBL] [Abstract][Full Text] [Related]
16. Deliberative processes in health technology assessment of medicines: the case of Spain.
Pinilla-Dominguez P; Pinilla-Dominguez J
Int J Technol Assess Health Care; 2023 Jul; 39(1):e50. PubMed ID: 37403252
[TBL] [Abstract][Full Text] [Related]
17. Addressing Health System Values in Health Technology Assessment: The Use of Evidence-Informed Deliberative Processes.
Oortwijn W; Klein P
Int J Technol Assess Health Care; 2019; 35(2):82-84. PubMed ID: 30957730
[TBL] [Abstract][Full Text] [Related]
18. The representation of public values in health technology assessment to inform funding decisions: the case of Australia's national funding bodies.
Haji Ali Afzali H; Street J; Merlin T; Karnon J
Int J Technol Assess Health Care; 2021 Jan; 37():e22. PubMed ID: 33455592
[TBL] [Abstract][Full Text] [Related]
19. Reinforcing Science and Policy, With Suggestions for Future Research Comment on "Evidence-Informed Deliberative Processes for Health Benefit Package Design - Part II: A Practical Guide".
Culyer AJ
Int J Health Policy Manag; 2023; 12():7398. PubMed ID: 35942975
[TBL] [Abstract][Full Text] [Related]
20. Principles for deliberative processes in health technology assessment.
Bond K; Stiffell R; Ollendorf DA
Int J Technol Assess Health Care; 2020 Aug; ():1-8. PubMed ID: 32746954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
